Endothelins and their receptors in cirrhotic and neoplastic livers of Canadian and Chinese populations

Citation
L. Cai et al., Endothelins and their receptors in cirrhotic and neoplastic livers of Canadian and Chinese populations, ANTICANC R, 19(3B), 1999, pp. 2243-2247
Citations number
26
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
19
Issue
3B
Year of publication
1999
Pages
2243 - 2247
Database
ISI
SICI code
0250-7005(199905/06)19:3B<2243:EATRIC>2.0.ZU;2-A
Abstract
Background: Endothelins (ETs) are 21 amino acid peptides with widespread ti ssue distribution and functions. In this study, we retrospectively investig ated immunoreactive ET-I, ET-3 as well as ET receptors by ligand binding an d autoradiography in hepatic cirrhosis and neoplasms. Materials and Methods : Formalin fixed paraffin embedded tissues from 30 hepatocellular carcinoma s (HCC), 4 fibrolamellar carcinomas (FLC), and 7 liver metastatic adenocarc inomas (Ad) from colon were collected from the Pathology Department of Lond on Health Science Centre. Adjacent cirrhotic livers were obtained from 17 c ases and adjacent normal liver was present in 12 cases. In addition, 15 HCC s, 6 cirrhotic and 8 normal livers were obtained from Normal Bethune Univer sity for Medical Sciences in China. The slides were stained for ET-1 and ET -3 with a polyclonal antibody and scored. Autoradiographic localization of ET-receptors with I-125-ET- 1 was carried out in some of the cases. Results : In the normal liver, hepatocytes, biliary epithelium, vascular endotheliu m and smooth muscle cells were positive for both ET-1 and BT-3. Higher immn unoreactivity for ET-1 and ET-3 was seen in cirrhosis. HCCs showed variatio n in immunoreactivity, with overall scoring not different from normal liver s. FLCs showed consistent higher immunoreactivity for both ET-1 and ET-3, w hile in Ads the immunoreactivity was decreased. Increased ET-receptors, rep resenting both ETA and ETB subtypes were seen in both cirrhosis and in HCC, Conclusion: Alterations in both ETs and their receptors were found in cirr hosis and neoplastic liver diseases.